Javascript must be enabled to continue!
Application of High Entropy Alloys in Stent Implants
View through CrossRef
High entropy alloys (HEAs) are alloys with five or more principal elements. Due to these distinct concept of alloying, the HEA exhibits unique and superior properties. The outstanding properties of HEA includes higher strength/hardness, superior wear resistance, high temperature stability, higher fatigue life, good corrosion and oxidation resistance. Such characteristics of HEA has been significant interest leading to researches on these emerging field. Even though many works are done to understand the characteristic of these HEAs, very few works are made on how the HEAs can be applied for commercial uses. This work discusses the application of High entropy alloys in biomedical applications. The coronary heart disease, the leading cause of death in the United States kills more than 350,000 persons/year and it costs $108.9 billion for the nation each year in spite of significant advancements in medical care and public awareness. A cardiovascular disease affects heart or blood vessels (arteries, veins and capillaries) or both by blocking the blood flow. As a surgical interventions, stent implants are deployed to cure or ameliorate the disease. However, the high failure rate of stents has lead researchers to give special attention towards analyzing stent structure, materials and characteristics. Many works related to alternate material and/or design are carried out in recent time. This paper discusses the feasibility of CoCrFeNiMn and Al0.1CoCrFeNi HEAs in stent implant application. This work is based on the speculation that CoCrFeNiMn and Al0.1CoCrFeNi HEAs are biocompatible material. These HEAs are characterized to determine the microstructure and mechanical properties. Computational modeling and analysis were carried out on stent implant by applying CoCrFeNiMn and Al0.1CoCrFeNi HEAs as material to understand the structural behavior.
Title: Application of High Entropy Alloys in Stent Implants
Description:
High entropy alloys (HEAs) are alloys with five or more principal elements.
Due to these distinct concept of alloying, the HEA exhibits unique and superior properties.
The outstanding properties of HEA includes higher strength/hardness, superior wear resistance, high temperature stability, higher fatigue life, good corrosion and oxidation resistance.
Such characteristics of HEA has been significant interest leading to researches on these emerging field.
Even though many works are done to understand the characteristic of these HEAs, very few works are made on how the HEAs can be applied for commercial uses.
This work discusses the application of High entropy alloys in biomedical applications.
The coronary heart disease, the leading cause of death in the United States kills more than 350,000 persons/year and it costs $108.
9 billion for the nation each year in spite of significant advancements in medical care and public awareness.
A cardiovascular disease affects heart or blood vessels (arteries, veins and capillaries) or both by blocking the blood flow.
As a surgical interventions, stent implants are deployed to cure or ameliorate the disease.
However, the high failure rate of stents has lead researchers to give special attention towards analyzing stent structure, materials and characteristics.
Many works related to alternate material and/or design are carried out in recent time.
This paper discusses the feasibility of CoCrFeNiMn and Al0.
1CoCrFeNi HEAs in stent implant application.
This work is based on the speculation that CoCrFeNiMn and Al0.
1CoCrFeNi HEAs are biocompatible material.
These HEAs are characterized to determine the microstructure and mechanical properties.
Computational modeling and analysis were carried out on stent implant by applying CoCrFeNiMn and Al0.
1CoCrFeNi HEAs as material to understand the structural behavior.
Related Results
Novel functionalized and patterned surfaces for cardiovascular applications
Novel functionalized and patterned surfaces for cardiovascular applications
Nowadays, cardiovascular diseases are mainly treated by implantation of a metallic or polymeric mesh, called stent, which maintains the artery widely open. This technique shows ver...
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
Objectives
To evaluate the efficacy and safety of domestic long biodegradable polymer coated sirolimus eluting stents (Excel stent, Shandong JW) for treatment of ...
Effect of co-trimoxazole and N-acetylcysteine alone and in combination on bacterial adherence on ureteral stent surface
Effect of co-trimoxazole and N-acetylcysteine alone and in combination on bacterial adherence on ureteral stent surface
Abstract
To assess the effect of co-trimoxazole and N-acetylcysteine (NAC), alone and in combination, on bacterial adherence to biofilm forme...
One stent versus two stents for distal LM PCI: insights from the experience of a high volume center
One stent versus two stents for distal LM PCI: insights from the experience of a high volume center
Abstract
Introduction
Distal left main (LM) PCIremains a challenge. One of the most debated issues is whether to use a single vs...
Minimum stent area, stent expansion and ultrasonic flow ratio post pci: insights from multivessel talent trial
Minimum stent area, stent expansion and ultrasonic flow ratio post pci: insights from multivessel talent trial
Abstract
Background
Ultrasonic flow ratio (UFR) is a novel method for fast computation of fractional flow reserve (FFR) from int...
Fluid and Solid Mechanics in Stented Arteries
Fluid and Solid Mechanics in Stented Arteries
Abstract
Vascular stents are being used in increasing numbers to correct arterial flow limiting disorders. Although data exist on the in vivo performance of these de...
Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
Longitudinal stent elongation or shortening after deployment in the coronary arteries: which is dominant?
Abstract
Background
Stent manufacturers always record stent shortening data while they do not record stent elongation data. The aim of this study is...
Stent diameter and stent-related symptoms, does size matter? A systematic review and meta-analysis
Stent diameter and stent-related symptoms, does size matter? A systematic review and meta-analysis
The ureteral insertion of a silicone tube was first performed in 1967. A validated ureteral stent symptom questionnaire (USSQ) is used for an objective assessment of patient-report...

